ADTX Live signaler | Maksimer profitt med Getagraph.com

SELG 108219 min ago

@ $4.00

Utstedt: 13 feb 2024 @ 20:29

Avkastning: -40.25%

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Stats
Dagens volum	65 262.00
Gjennomsnittsvolum	372 577
Markedsverdi	4.69M
EPS	$0 ( 2024-04-02 )
Neste inntjeningsdato	( $-3.33 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0200
ATR14	$0.0500 (2.08%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-08	Runge Jeffrey W.	Buy	470	Options (right to buy)
2023-11-08	Albanna Rowena	Buy	4 702	Options (right to buy)
2023-11-08	Nelson Charles Athle	Buy	470	Options (right to buy)
2023-11-08	Albanna Amro A.	Buy	9 404	Options (right to buy)
2023-11-08	Pankovcin Corinne	Buy	4 702	Options (right to buy)

INSIDER POWER
26.52
Last 84 transactions
Buy: 1 934 500 \| Sell: 1 185 103

Volum Korrelasjon

Lang: 0.10 (neutral)

Kort: -0.80 (moderate negative)

Signal:(42.192) Neutral

ADiTx Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner
OGI	0.974
BNGO	0.971
VERB	0.971
CNXC	0.968
IMBI	0.965
NESR	0.965
MRIN	0.964
WATT	0.963
MMAT	0.962
DISH	0.961

10 Mest negative korrelasjoner
MSDA	-0.971
ADAL	-0.966
TIOAU	-0.961
TIOA	-0.961
BRIV	-0.96
LEGA	-0.959
ZING	-0.959
SKYA	-0.958
CRZN	-0.957
VLAT	-0.957

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

ADiTx Therapeutics, Inc. Korrelasjon - Valuta/Råvare

0.65
( weak )

0.62
( weak )

0.00
( neutral )

0.55
( weak )

-0.26
( neutral )

-0.46
( neutral )

ADiTx Therapeutics, Inc. Økonomi

Annual	2023
Omsetning:	$645 176
Bruttogevinst:	$-654 243 (-101.41 %)
EPS:	$-107.10

FY	2023
Omsetning:	$645 176
Bruttogevinst:	$-654 243 (-101.41 %)
EPS:	$-107.10

FY	2022
Omsetning:	$933 715
Bruttogevinst:	$166 936 (17.88 %)
EPS:	$-608.04

FY	2021
Omsetning:	$105 034
Bruttogevinst:	$27 055.00 (25.76 %)
EPS:	$-6.72

Financial Reports:

No articles found.

ADiTx Therapeutics, Inc.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.